LocWolf
2 days ago
Now don't cut this in stone as I have been wrong so many time it taint funny but.............
The patent of interest 11,105,808 B2 was continued from an application and possibly (as I see it) patent 9,952,221B2.
Within the above the U.S. Patent No. 9,952,221 "Methods for Screening, Predicting and Monitoring Prostate Cancer" should expire on 01/24/2022. Also the U.S. Patent Publication No. 2018/0321245 Methods for Screening, Predicting and Monitoring Prostate Cancer should expire on 01/24/2022.
It appears to me that patent 11,105,808 B2 might be a continuation but has it expired? It was extended 394 days but was that from 8/31/21 or what?
I see a clear difference in the two patents claim wise and writing clarity/skills. Could Guyon modify the newest patents or perhaps it is being developed as we wait or is the Locwolf howling & scratching at the cage walls.
Hey! I gotta be entertaining once in a while.
Good Sport
3 weeks ago
Loc,
Any guess as to when that 11,105,808 B patent will expire? I didn't quite understand the prior patents that made up this and then the * mark stating it was subject to early "terminal" termination whatever that means. It also has a little over a year of additional extention to it from uspto.
Also, do you think NeoGenomics is still in our mix again as possible partners for this? I see their stock price is trading at a little under $15 currently.
RELATED APPLICATIONS
This is a continuation of application Ser. No. 14/754,434, filed Jun. 29, 2015, issued as U.S. Pat. No. 9,952,221, which is a continuation of application Ser. No. 12/349,437, filed Jan. 6, 2009, now abandoned, which is a continuation-in-part of application Ser. No. 12/327,823, filed Dec. 4, 2008, now abandoned, which is a continuation-in-part of application Ser. No. 12/025,724, filed Feb. 4, 2008, now abandoned, which claims the priority of Provisional Application No. 60/888,070, filed Feb. 2, 2007, and is a continuation-in-part of application Ser. No. 11/274,931, filed Nov. 14, 2005, now abandoned, which claims the priority of each of Provisional Applications No. 60/627,626, filed Nov. 12, 2004, and No. 60/651,340, filed Feb. 9, 2005.
Patent History
Patent number: 11105808
Type: Grant
Filed: Apr 12, 2018
Date of Patent: Aug 31, 2021
Patent Publication Number: 20180321245
Assignee: HEALTH DISCOVERY CORPORATION (Atlanta, GA)
Inventor: Isabelle Guyon (Berkeley, CA)
Primary Examiner: Peter J Reddig
Application Number: 15/952,186